Filing Flows

Filing Flows › 13F managers › Lilly Endowment Inc

Lilly Endowment Inc: 13F portfolio Q3 2026 and what copying it returned

Lilly Endowment Inc's 13F for the quarter ended 2026-09-30 (filed Oct 19, 2026): 1 common-share position, $104.2B reported. Copying each 13F the day after it was filed returned +335.3% from Jun 2, 2022 to Nov 6, 2026, against +79.5% for SPY.

Reported 13F assets$104.2B
Positions (common)1
Quarter2026-09-30
Clone return+335.3%
SPY, same days+79.5%
Clone max drawdown-34.8%

Copying the 13F

2022-062023-032023-122024-092025-062026-032026-11cloneSPY

Each 13F bought at the close of the first trading day after it was filed and held, drifting, until the next one; value-weighted over the common-share positions with a price (100.0% of the portfolio on average); 19 filings since Oct 15, 2013. Price returns for the clone and SPY alike (no dividends, no costs). A 13F lists only US long positions at quarter end, reported up to 45 days later.

Largest holdings (2026-09-30)

Lilly Endowment Inc: largest 13F holdings, 2026-09-30Lilly Endowment Inc: largest 13F holdings, 2026-09-30LLY · ELI Lilly$104.2B
Lilly Endowment Inc: positions grown and trimmed in the quarter (change in shares; new positions and exits are listed below)Lilly Endowment Inc: positions grown and trimmed in the quarter (change in shares; new positions and exits are listed below)LLY0%
TickerCompanyWeightValueChange in the quarter
LLYELI Lilly100.0%$104.2B-0.3%

Biggest adds

Biggest cuts

Track record

Of 1 position change scored in 1 separate decision, 100.0% were on the right side of SPY over the next three months (Disclosures → Smart money).

Open in Disclosures → every quarter, the clone month by month, the smart-money record

Source: SEC Form 13F-HR, filer CIK 316011. Not investment advice.